 |
|
Lung Cancer Trial Results
6. Post-Surgery Chemotherapy Boosts Survival for NSCLC Patients
(Posted: 06/02/2003, Updated: 02/10/2004) - A large international study has shown that patients with the most common form of lung cancer -- non-small cell lung cancer, or NSCLC – may live longer if they are treated with chemotherapy after surgery. These results may justify post-operative chemotherapy for NSCLC patients in otherwise good health.
7. Three-Pronged Approach an Added Treatment Option for Metastatic NSCLC
(Posted: 06/02/2003) - Patients with non-small-cell lung cancer (NSCLC) that has spread to surrounding lymph nodes who were treated with a three-pronged approach using chemotherapy, radiation, and surgery lived longer without progression of their disease than patients treated with just chemotherapy and radiation. However, it remains unclear whether three-pronged treatment extends patients’ overall survival compared to the two-pronged approach.
8. Surgery Helps Relieve Spinal Cord Compression Caused by Metastatic Cancer
(Posted: 06/02/2003) - Surgery followed by radiation is more effective than radiation alone in treating spinal cord compression caused by metastatic cancer.
9. Heart Risks of Doxorubicin Higher Than Previously Reported
(Posted: 05/28/2003) - A study in the June 1, 2003, issue of the journal Cancer
suggests that the drug doxorubicin (Adriamycin®), widely used in cancer chemotherapy, causes congestive heart failure more frequently and at lower doses than has been reported in the past.
10. Some Survival Benefit from Multidrug Treatment for Advanced Non-Small Cell Lung Cancer
(Posted: 05/20/2002) - A comparison of two approaches to the treatment of advanced non-small cell lung cancer (NSCLC) found that patients who received a two-drug combination therapy had a median survival that was two months longer than patients who received the single agent paclitaxel (brand name Taxol®), researchers reported at the annual meeting of the American Society of Clinical Oncology in Orlando, Fla., on May 20, 2002.
< Previous 1 2 3 4 Next >
|
|
|
